Trial · NCT02108743
Albuterol and Dynamic Hyperinflation in Idiopathic Pulmonary Arterial Hypertension
NCT02108743, Phase 2, Withdrawn, American Medical Association Foundation
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Albuterol and Dynamic Hyperinflation in Idiopathic Pulmonary Arterial Hypertension. Trials, record NCT02108743. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02108743
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Albuterol and Dynamic Hyperinflation in Idiopathic Pulmonary Arterial Hypertension
- NCT number
- NCT02108743
- Status
- Withdrawn
- Phases
- Phase 2
- Enrollment
- 0 participants, actual
- Lead sponsor
- American Medical Association Foundation
- Conditions
- Idiopathic Pulmonary Arterial Hypertension.
- Interventions
- Albuterol., Normal saline placebo
- First posted
- 2014-04-09
- Last updated
- 2015-12-30
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | End-expiratory lung volume:total lung capacity (EELV/TLC) ratio at matched metabolic isowork. | up to 3 days | Determined by measuring inspiratory capacity every 2 minutes during cardiopulmonary exercise test (CPET) |
| Secondary | Change in peak oxygen consumption with albuterol | Study days 2 and 3 | Measured at the end of CPET |
| Secondary | Change in O2 pulse with albuterol. | Study days 2 and 3 | Measured throughout CPET and compared at matched metabolic isotimes |
| Secondary | Exercise time | Study days 2 and 3 | Total ramped exercise time |
| Secondary | Borg dyspnea score | Days 2 and 3 | Measured every 2 minutes throughout CPET |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers4
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02108743
GET https://conductscience.org/api/trials/v1/NCT02108743/registered